Stock A314130 GENOME & COMPANY
Add to a list
To use this feature you must be a member
Log inSign up

Charts Genome & Company

Equities

A314130

KR7314130006

End-of-day quote Korea S.E.
Other stock markets
 06:00:00 2024-04-29 pm EDT 		5-day change 1st Jan Change
6,910 KRW +2.98% Intraday chart for Genome & Company -1.71% -44.68%
Jan. 24 Genome & Company Announces Positive Topline Results from Phase 2 Clinical Trial of Combination of GEN-001 and Bavencio®? for the Treatment of Gastric Cancer Poster Presented at ASCO GI CI
2023 Genome & Company Announces Positive Results from Interim Analysis of Gen-001 Plus Avelumab (Bavencio®?) Phase II Trial CI

Chart: Technical Analysis

  1. Stock Market
  2. Equities
  3. A314130 Stock
  4. Charts Genome & Company